{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T04:05:49Z","timestamp":1683086749163},"reference-count":33,"publisher":"SLACK, Inc.","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Ann"],"published-print":{"date-parts":[[2004,9]]},"abstract":"<jats:p>Routine use of meningococcal vaccine may prevent significant morbidity.<\/jats:p>","DOI":"10.3928\/0090-4481-20040901-10","type":"journal-article","created":{"date-parts":[[2014,5,27]],"date-time":"2014-05-27T18:16:32Z","timestamp":1401214592000},"page":"590-595","source":"Crossref","is-referenced-by-count":1,"title":["Rates of Neisseria Meningitidis: Increasing in Young Adults"],"prefix":"10.3928","volume":"33","author":[{"given":"Sunanda","family":"Gaur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amisha","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Whitley-Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2308","reference":[{"key":"e_1_3_1_2_1","unstructured":"1. Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MAfWA Recomm Rep. 2000;498(RR-7):1-10."},{"key":"e_1_3_1_3_1","doi-asserted-by":"crossref","unstructured":"2. OfRt PA Peter G. The meningococcal vaccine - public policy and individual choices. N Engl J Med. 2003;349(24):2353-2356.","DOI":"10.1056\/NEJMsb035678"},{"key":"e_1_3_1_4_1","unstructured":"3. Meningococcal disease and college students. Recommendations of the Advisory Committee on Immunization Practices (ACTP). MMWR Recomm Rep. 2000;49(RR-7): 13-20."},{"key":"e_1_3_1_5_1","doi-asserted-by":"crossref","unstructured":"4. Rosenstein NE Perkins BA Stephens DS et al. The changing epidemiology of meningococcal disease in the United States 1992- 1 996. J Infect Dis. 1999;180(6):1894-1901.","DOI":"10.1086\/315158"},{"key":"e_1_3_1_6_1","doi-asserted-by":"crossref","unstructured":"5. Greenwood B. Meningococcal meningitis in Africa. Trans R Soc Trop Med Hyg. 1999;93(4):341-353.","DOI":"10.1016\/S0035-9203(99)90106-2"},{"key":"e_1_3_1_7_1","doi-asserted-by":"crossref","unstructured":"6. Novelli VM Lewis RG Dawood ST. Epidemic group A meningococcal disease in Haj pilgrims. Lancet. 198?;2(8563):863.","DOI":"10.1016\/S0140-6736(87)91056-7"},{"key":"e_1_3_1_8_1","doi-asserted-by":"crossref","unstructured":"7. Tana MK Achtman M Alonso JM et al. Serogroup W 135 meningococcal disease in Hajj pilgrims. Lancet. 2000;356(9248):2I59.","DOI":"10.1016\/S0140-6736(00)03502-9"},{"key":"e_1_3_1_9_1","doi-asserted-by":"crossref","unstructured":"8. Goldschneider I Gotschlich EC Artenstein MS. Human immunity to die meningococcus. I. The role of humoral antibodies. J Exp Med. 1969; 129(6): 1307- 1326.","DOI":"10.1084\/jem.129.6.1307"},{"key":"e_1_3_1_10_1","doi-asserted-by":"crossref","unstructured":"9. Rosenstein NE. Perkins BA Stephens DS Popovic T Hughes JM. Meningococcal disease. N Engl J Med. 2001;344(18):1378-1388.","DOI":"10.1056\/NEJM200105033441807"},{"key":"e_1_3_1_11_1","unstructured":"10. Woods CR Rosenstein N Perkins BA. Neisseria meningitis ou\u00f6weaks in die United States 1994-97. Presented at: 38th Annual Meeting of the Infectious Disease Society of America. November 12-15 1998; Denver CO."},{"key":"e_1_3_1_12_1","unstructured":"11. Apicella MA. Neisseria meningitides. In: Mandell GL Bennett JE Dolin R eds. Principles and Practice of Infectious Diseases. 5di ed. Vol 2. Philadelphia PA: Churchill Livingstone; 2000:2228-2241."},{"key":"e_1_3_1_13_1","doi-asserted-by":"crossref","unstructured":"12. Fume J Bitter-Suermann D Goridis C Finne U. An IgG monoclonal antibody to group B meningococci cross-reacts wim developmentally regulated polysialic acid units of glycoproteins in neural and extranearal tissues. J Immunol. 1987;138(12):4402-4407.","DOI":"10.4049\/jimmunol.138.12.4402"},{"key":"e_1_3_1_14_1","doi-asserted-by":"crossref","unstructured":"13. Rosenstein NE Fischer M Tappero JW. Meningococcal vaccines. Infect Dis Clin North Am. 2001;15(1 ):155-169.","DOI":"10.1016\/S0891-5520(05)70273-7"},{"key":"e_1_3_1_15_1","unstructured":"14. Meningococcal vaccines: polysaccharide and polysaccharide conjugate vaccines. WkIy Epidemiol Ree. 2002;77(40):33 1-339."},{"key":"e_1_3_1_16_1","doi-asserted-by":"crossref","unstructured":"15. Wildes SS Tunkel AR. Meningococcal vaccines: a progress report. BioDrugs. 2002; 16(5):32 1-329.","DOI":"10.2165\/00063030-200216050-00001"},{"key":"e_1_3_1_17_1","doi-asserted-by":"crossref","unstructured":"16. Dull P Rosenstein N. Meningococcal disease and vaccines. Pediatr Ann. 2001;3O(6):358361.","DOI":"10.3928\/0090-4481-20010601-12"},{"key":"e_1_3_1_18_1","doi-asserted-by":"crossref","unstructured":"17. Soriano-Gabarro M Stuart JM Rosenstein NE. Vaccines for die prevention of meningococcal disease in children. Semin Pediatr Infect Dis. 2002; 1 3(3): 182- 189.","DOI":"10.1053\/spid.2002.125861"},{"key":"e_1_3_1_19_1","unstructured":"18. Control and prevention of serogroup C meningococcal disease: evaluation and management of suspected outiweaks: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1997;46(RR-5): 13-21."},{"key":"e_1_3_1_20_1","doi-asserted-by":"crossref","unstructured":"19. Meningococcal disease prevention and control strategies for practice-based physicians (Addendum: recommendations for college students). Committee on Infectious Diseases. Pediatrics. 2000;106(6).:1500-1504.","DOI":"10.1542\/peds.106.6.1500"},{"key":"e_1_3_1_21_1","unstructured":"20. Keyserling HL Papa T Bybel M. A comparative trial of the safety and immunogenicity of an experimental tetravalent meningococcal (A C Y W- 1 35) diphdieria conjugate vaccine versus a licensed meningococcal (A C Y and W135) polysaccharide vaccine in healm adolescents. Presented at: 43rd Interscience Conference on Antimicrobal Agents and Chemotiierapy. September 14-17. 2003; Chicago IL."},{"key":"e_1_3_1_22_1","unstructured":"21. Pichichero ME Casey JR Papa T et al. A comparative trial of die safety and immunogeniciry of quadrivalent (A C Y W- 135) meningococcal diptheria conjugate vaccine (MCV-4) versus quadrivalent polysaccharide vaccine (menomune ps) in children 2- 1 0 years of age. Presented at: 43rd Interscience Conference on Antimicrobal Agents and Cbemotiierapy. September 14-17. 2003; Chicago. DL."},{"key":"e_1_3_1_23_1","unstructured":"22. Wachter K. New conjugate meningococcal vaccine on scene. Ped News. 2004:38(3): 1 L"},{"key":"e_1_3_1_24_1","doi-asserted-by":"crossref","unstructured":"23. Rennels MB Edwards KM Keyserling HL et al. Safety and immunogenicity of four doses of Neisseria meningitidis group C vaccine conjugated to CRM 197 in United States infants. Pediatr Infect Dis J. 2001;2C<2):153-159.","DOI":"10.1097\/00006454-200102000-00007"},{"key":"e_1_3_1_25_1","doi-asserted-by":"crossref","unstructured":"24. Choo S Zuckerman J Goilav C et al. Immunogenicity and reactogenicity of a group C meningococcal conjugate vaccine compared with a group A+C meningococcal polysaccharide vaccine in adolescents in a randomised observer-blind controlled trial. Vaccine. 2000;18(24):2686-2692.","DOI":"10.1016\/S0264-410X(00)00050-5"},{"key":"e_1_3_1_26_1","doi-asserted-by":"crossref","unstructured":"25. Richmond P Borrow R Goldblatt D et al. Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers. J Infect Dis. 2001;183(1):160-163.","DOI":"10.1086\/317646"},{"key":"e_1_3_1_27_1","doi-asserted-by":"crossref","unstructured":"26. Miller E Salisbury D Ramsay M. Planning registration and implementation of an immunisation campaign against meningococcal serogroup C disease in die UK: a success story. Vaccine. 2001 ;20(Suppl 1):S58-S67.","DOI":"10.1016\/S0264-410X(01)00299-7"},{"key":"e_1_3_1_28_1","doi-asserted-by":"crossref","unstructured":"27. Balmer P Borrow R Miller E. Impact of meningococcal C conjugate vaccine in the UK. J Med Microbio! 2002;51(9):7 17-722.","DOI":"10.1099\/0022-1317-51-9-717"},{"key":"e_1_3_1_29_1","doi-asserted-by":"crossref","unstructured":"28. Ruggeberg J Heath PT. Safety and efficacy of meningococcal group C conjugate vaccines. Expert Opin Drug Saf. 2O03;2(l):7-19.","DOI":"10.1517\/14740338.2.1.7"},{"key":"e_1_3_1_30_1","doi-asserted-by":"crossref","unstructured":"29. Ramsay ME Andrews NJ Trotter CL Kaczmarski EB Miller E. Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis. BMJ. 2003;326(7385):365-366.","DOI":"10.1136\/bmj.326.7385.365"},{"key":"e_1_3_1_31_1","doi-asserted-by":"crossref","unstructured":"30. MacLennan J Obaro S Deeks J et al. Immunologic memory 5 years after meningococcal A\/C conjugate vaccination in infancy. J Infect Dis. 2001 ; 1 83( 1 ):97- 1 04.","DOI":"10.1086\/317667"},{"key":"e_1_3_1_32_1","doi-asserted-by":"crossref","unstructured":"31. MacLennan J Shackley F Heath PT et al. Safety immunogenicity and induction of immunologic memory by a serogroup C meningococcal conjugate vaccine in infants: a randomized controlled trial. JAMA. 2000;283(21):2795-2801.","DOI":"10.1001\/jama.283.21.2795"},{"key":"e_1_3_1_33_1","doi-asserted-by":"crossref","unstructured":"32. Bramley JC Hall T Finn A et al. Safety and immunogenicity of diree lots of meningococcal serogroup C conjugate vaccine administered at 2 3 and 4 months of age. Vaccine. 2001;1 9(20-22):2924-2931.","DOI":"10.1016\/S0264-410X(00)00528-4"},{"key":"e_1_3_1_34_1","doi-asserted-by":"crossref","unstructured":"33. Maiden MC Stuart JM; UK Meningococcal Carraige Group. Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination. Lancet. 20O2;359(9320): 1 829-1831.","DOI":"10.1016\/S0140-6736(02)08679-8"}],"container-title":["Pediatric Annals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.healio.com\/doiresolver?doi=10.3928\/0090-4481-20040901-10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T23:02:33Z","timestamp":1683068553000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.healio.com\/doi\/10.3928\/0090-4481-20040901-10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["10.3928\/0090-4481-20040901-10"],"URL":"https:\/\/doi.org\/10.3928\/0090-4481-20040901-10","relation":{},"ISSN":["0090-4481","1938-2359"],"issn-type":[{"value":"0090-4481","type":"print"},{"value":"1938-2359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}